Regulatory Affairs Specialist Interview Questions
Prepare for your Regulatory Affairs Specialist interview. Understand the required skills and qualifications, anticipate the questions you may be asked, and study well-prepared answers using our sample responses.
Interview Questions for Regulatory Affairs Specialist
If we hired you as our first Regulatory Affairs specialist, what would your 90-day plan look like?
Walk me through how you decide the appropriate U.S. regulatory pathway for a novel medical device.
For software as a medical device (SaMD), how do you approach classification and compliance planning?
What’s your strategy for EU MDR compliance, including selecting and working with a Notified Body?
Tell me about a time you integrated design controls into an agile development process without slowing the team down.
How would you build a phase-appropriate quality management system (QMS) for a startup preparing for its first submission?
What is your process for developing a clinical evidence strategy for a device that’s novel but moderate risk?
How do you handle promotional claims review in a startup where marketing needs speed and guidance?
Describe a time you received an FDA Additional Information (AI) request or Notified Body nonconformity. How did you address it and prevent repeats?
How would you set up post‑market surveillance and complaint handling with limited resources?
What has been your experience implementing UDI in the U.S. and preparing for EUDAMED?
Imagine engineering proposes a late design change two weeks before a planned submission. How do you assess and decide whether to include it or defer?
Tell me about a time you influenced product scope to reduce regulatory risk without sacrificing customer value.
How do you prepare and run an effective FDA Q-Sub or Notified Body consultation?
What tools and documentation systems have you used to manage regulatory deliverables, and what do you prefer in a startup?
How do you stay current with evolving regulations and standards, and how do you translate changes into action for the team?
Describe a situation where regulatory requirements were ambiguous. How did you make a decision and communicate the rationale?
How do you collaborate with engineering, clinical, and product to align user needs, risks, and claims from day one?
What metrics would you track to measure Regulatory Affairs effectiveness in our first year?
How do you balance speed-to-market with compliance when leadership is pushing hard on timelines?
If we pivot to a new indication or primary market, how would you rework the regulatory strategy quickly?
What is your experience with audits and inspections, and how would you get us inspection-ready?
Why are you interested in this Regulatory Affairs role at our startup, and how would you contribute to our culture?
Where do you want to grow professionally over the next 2–3 years, and how do you invest in your development?
-
If we hired you as our first Regulatory Affairs specialist, what would your 90-day plan look like?
Employers ask this question to see if you can create structure from ambiguity and prioritize what matters in an early-stage environment. In your answer, outline a phased plan that covers immediate gaps (risk, QMS, labeling), near-term regulatory strategy, and quick wins that de-risk timelines.
Answer Example: "In the first 30 days, I’d map the product(s), intended use/claims, and current documentation, then run a gap assessment against applicable regulations and standards. By 60 days, I’d establish a phase-appropriate QMS (SOPs for design control, document control, complaint handling) and draft the regulatory strategy and timeline. By 90 days, I’d complete a pre-submission package to align with FDA/Notified Body and set a cross-functional rhythm for requirements, risk, and claims review."
Help us improve this answer. / -
Walk me through how you decide the appropriate U.S. regulatory pathway for a novel medical device.
Employers ask this question to gauge your grasp of classification, predicates, and when to pursue 510(k), De Novo, or PMA. In your answer, show a structured approach: intended use/claims, risk profile, technology, predicate search, and interactions with FDA such as a Q-Sub.
Answer Example: "I start with intended use and claims, map the device to classification regulations and product codes, and analyze risk and technological characteristics. I conduct a thorough predicate search; if no suitable predicate exists or there’s a new intended use, I evaluate De Novo versus PMA based on risk. I’ll use an FDA Q-Sub to validate the pathway and align on testing expectations before locking the plan."
Help us improve this answer. / -
For software as a medical device (SaMD), how do you approach classification and compliance planning?
Employers ask this to ensure you can handle software-heavy products common in startups. In your answer, reference IMDRF SaMD framework, risk categorization, and key standards (IEC 62304, IEC 82304-1, ISO 14971) plus cybersecurity and real-world performance considerations.
Answer Example: "I use IMDRF to determine SaMD category based on the healthcare situation and significance of information, then align U.S. classification with product codes and guidance. I build a plan around IEC 62304 for software lifecycle, 82304-1 for health software safety, 14971 for risk, and FDA’s cybersecurity guidance. I also define clinical/performance evidence and post-market monitoring for algorithm updates."
Help us improve this answer. / -
What’s your strategy for EU MDR compliance, including selecting and working with a Notified Body?
Employers ask this to see if you understand MDR’s heightened requirements and NB capacity constraints. In your answer, address classification, Annex II/III technical documentation, clinical evaluation (Annex XIV), PMS/PMCF, and how you assess and engage an NB early.
Answer Example: "I classify under MDR using Annex VIII, then plan the technical file per Annex II/III with strong clinical evaluation and risk management. I identify candidate Notified Bodies aligned to our device scope and capacity, engage them early with a briefing package, and confirm expectations. I build a PMS/PMCF plan to meet MDR’s evidence bar and reduce surprises during conformity assessment."
Help us improve this answer. / -
Tell me about a time you integrated design controls into an agile development process without slowing the team down.
Employers ask this to assess your ability to be pragmatic and collaborative. In your answer, show how you met regulatory requirements (user needs, inputs/outputs, verification/validation, traceability) while preserving speed.
Answer Example: "On a SaMD project, I created lightweight templates and integrated requirements and risk updates into sprint reviews. We maintained a live traceability matrix in Jira to capture user needs through verification, and scheduled V&V gates aligned to release trains. We passed an external audit with no design control observations and kept two-week sprints intact."
Help us improve this answer. / -
How would you build a phase-appropriate quality management system (QMS) for a startup preparing for its first submission?
Employers ask this to ensure you can scale process without overburdening a small team. In your answer, describe prioritizing core SOPs, choosing tools, training, and a roadmap to expand as the company grows.
Answer Example: "I’d start with document control, training, design control, risk management, supplier management, complaint handling, and CAPA. I prefer a lightweight eQMS or a disciplined SharePoint with clear ownership and training records, then layer additional SOPs as needs arise. I run short training sessions to build buy-in and set simple metrics for adherence."
Help us improve this answer. / -
What is your process for developing a clinical evidence strategy for a device that’s novel but moderate risk?
Employers ask this to evaluate your understanding of evidence thresholds and options. In your answer, cover literature/real-world data, performance testing, potential clinical studies, and engagement with regulators to confirm the plan.
Answer Example: "I begin with a gap analysis comparing intended claims to available literature and bench/performance data. If needed, I outline a targeted clinical study with endpoints tied to risk controls and claims, and I draft a CEP/SSCP for EU. I’d validate the plan in a pre-sub to ensure FDA agrees the evidence is fit for purpose."
Help us improve this answer. / -
How do you handle promotional claims review in a startup where marketing needs speed and guidance?
Employers ask this to see how you balance growth with compliance and avoid enforcement risk. In your answer, show a repeatable process for claims substantiation, fair balance, and collaboration with marketing and legal.
Answer Example: "I establish a fast review workflow with checklists tied to cleared/approved indications, prohibited/off-label areas, and required disclosures. I coach marketing on claim categories (clinical, comparative, functionality) and ensure every claim traces back to evidence. We track turnaround times and pre-approve reusable claim libraries to keep velocity high."
Help us improve this answer. / -
Describe a time you received an FDA Additional Information (AI) request or Notified Body nonconformity. How did you address it and prevent repeats?
Employers ask this to understand your problem-solving and root cause skills. In your answer, outline how you analyzed the deficiency, aligned cross-functionally, responded clearly with evidence, and implemented systemic fixes.
Answer Example: "In a 510(k), FDA questioned our biocompatibility justification for a coating change. I convened RA, R&D, and the lab, provided missing extraction details, and added supplemental cytotoxicity data. We updated our change control SOP to trigger earlier tox consultation, and the submission was cleared after our response."
Help us improve this answer. / -
How would you set up post‑market surveillance and complaint handling with limited resources?
Employers ask this to see if you can create lean, compliant systems. In your answer, describe signal detection, complaint intake/triage, vigilance reporting, and how you close the loop into risk management and labeling.
Answer Example: "I’d implement a simple intake channel with defined triage criteria, a complaint log with seriousness coding, and clear timelines for MDR/IVDR or FDA reporting. I’d review trends monthly, feed signals into the risk file and CAPA when thresholds are met, and summarize in PMS reports. Training frontline teams on what constitutes a complaint keeps the system effective."
Help us improve this answer. / -
What has been your experience implementing UDI in the U.S. and preparing for EUDAMED?
Employers ask this to confirm you can manage labeling data and timelines. In your answer, reference device identifiers, data attributes, submission tools, and cross-functional coordination with operations and IT.
Answer Example: "I’ve created UDI assignment rules by model and packaging level, coordinated label updates, and submitted data to GUDID. For EU, I prepared master data sets for EUDAMED modules and aligned with NB and distributors on timing. I partner with operations to integrate UDI into ERP to avoid manual errors."
Help us improve this answer. / -
Imagine engineering proposes a late design change two weeks before a planned submission. How do you assess and decide whether to include it or defer?
Employers ask this to evaluate your risk-based decision-making under time pressure. In your answer, explain impact analysis across safety, performance, verification, labeling, and submission narrative, plus how you document the rationale.
Answer Example: "I’d run a change impact assessment with R&D and QA, checking if the change affects intended use, risk controls, or verification. If it strengthens performance without altering claims and testing can be completed quickly, I’d include it; otherwise, I’d defer and document the change for a supplemental update. I’d record the rationale in change control and the submission strategy memo."
Help us improve this answer. / -
Tell me about a time you influenced product scope to reduce regulatory risk without sacrificing customer value.
Employers ask this to see your ability to shape the product thoughtfully. In your answer, show how you quantified risk/benefit, proposed alternatives, and built consensus.
Answer Example: "On a diagnostics project, a high-risk comparative claim would have triggered a larger clinical trial. I proposed limiting the initial claim set to performance within a defined population and adding the comparative claim post-clearance with real-world evidence. We met launch timelines and phased in stronger claims later."
Help us improve this answer. / -
How do you prepare and run an effective FDA Q-Sub or Notified Body consultation?
Employers ask this to gauge your ability to de-risk milestones through early engagement. In your answer, cover question framing, briefing packages, meeting execution, and how you document decisions.
Answer Example: "I define 3–5 focused questions where FDA/NB input changes our plan, build a concise briefing package with clear proposals, and prep SMEs with a script. During the meeting, I confirm agreements and action items on the record. I follow with a meeting memo and adjust test plans, clinical strategy, or submission pathway accordingly."
Help us improve this answer. / -
What tools and documentation systems have you used to manage regulatory deliverables, and what do you prefer in a startup?
Employers ask this to understand your tooling fluency and pragmatism. In your answer, mention eQMS/RIMS options, traceability solutions, eSTAR for 510(k), and how you keep teams aligned without over-engineering.
Answer Example: "I’ve used Greenlight Guru and Veeva for QMS and document control, and Jira/Jama for requirements and traceability. For FDA, I’ve built 510(k)s in eSTAR, which streamlines structure and RTA checks. In a startup, I choose lean tools with strong version control and templates, then scale as complexity grows."
Help us improve this answer. / -
How do you stay current with evolving regulations and standards, and how do you translate changes into action for the team?
Employers ask this to see continuous learning and practical application. In your answer, cite credible sources and how you convert intelligence into SOP updates, training, or strategy shifts.
Answer Example: "I monitor FDA guidances, IMDRF, MDCG papers, standards updates, and NB newsletters, and I’m active in RAPS and AAMI communities. Each quarter, I summarize relevant changes, assess impact, and propose updates to SOPs, templates, or test plans. I run short trainings so teams know what’s changing and why."
Help us improve this answer. / -
Describe a situation where regulatory requirements were ambiguous. How did you make a decision and communicate the rationale?
Employers ask this to evaluate judgment under uncertainty. In your answer, highlight your evidence review, benchmarking, consultation with experts/regulators, and transparent documentation.
Answer Example: "For a novel workflow claim, guidance was silent. I reviewed similar product decisions, consulted with external advisors, and took a Q-Sub to validate our proposal. I documented the rationale, risks, and mitigations, aligned leadership, and proceeded with a plan FDA later endorsed."
Help us improve this answer. / -
How do you collaborate with engineering, clinical, and product to align user needs, risks, and claims from day one?
Employers ask this to ensure you can operate cross-functionally in small teams. In your answer, describe rituals and artifacts that keep everyone synchronized.
Answer Example: "I co-facilitate early user needs and hazard analyses, then maintain a living traceability matrix that connects needs, requirements, risks, and V&V. We review proposed claims and evidence in a monthly cross-functional forum. This keeps scope realistic and reduces last-minute surprises."
Help us improve this answer. / -
What metrics would you track to measure Regulatory Affairs effectiveness in our first year?
Employers ask this to see if you’re outcome-oriented and data-driven. In your answer, choose a few meaningful, controllable metrics tied to speed, quality, and risk.
Answer Example: "I track submission readiness (on-time document completion), deficiency rate and cycle times, change control lead time, and promo review turnaround. I also monitor post-market signal closure times and training completion. These metrics show both velocity and compliance health."
Help us improve this answer. / -
How do you balance speed-to-market with compliance when leadership is pushing hard on timelines?
Employers ask this to test your backbone and pragmatism. In your answer, show how you frame trade-offs, propose alternatives, and protect patient safety and company risk profile.
Answer Example: "I put options on the table with quantified timeline and risk impacts, including a compliant minimum viable claim set or phased submissions. I’m transparent about non-negotiables tied to patient safety and enforcement risk. This approach maintains urgency while avoiding costly rework or regulatory setbacks."
Help us improve this answer. / -
If we pivot to a new indication or primary market, how would you rework the regulatory strategy quickly?
Employers ask this to assess adaptability in a startup setting. In your answer, outline a rapid gap assessment, regulatory intelligence check, and a revised plan with critical path changes.
Answer Example: "I’d validate the new intended use and target market, re-map classification and evidence requirements, and check guidance and standards. I’d draft a delta plan highlighting new tests, clinical needs, or NB/FDA interactions and update the timeline and resourcing. Within two weeks, I’d seek alignment with leadership and external parties."
Help us improve this answer. / -
What is your experience with audits and inspections, and how would you get us inspection-ready?
Employers ask this to ensure you can prepare a small team for scrutiny. In your answer, discuss mock audits, storyboarding, document readiness, and training SMEs to answer effectively.
Answer Example: "I’ve supported FDA and NB audits, leading readiness reviews and CAPA closure. I run a mock audit focused on design controls, risk, and complaints, create a document index and storyboards, and brief SMEs on concise, truthful responses. We fix gaps preemptively and set a calm, controlled inspection room process."
Help us improve this answer. / -
Why are you interested in this Regulatory Affairs role at our startup, and how would you contribute to our culture?
Employers ask this to gauge motivation and culture fit. In your answer, connect your experience to their mission and show how you add value beyond your job description.
Answer Example: "I’m excited by your mission and the chance to build a scalable regulatory foundation that accelerates patient impact. I bring a collaborative, low-ego style and enjoy teaching non-regulatory teammates how to ship compliant products fast. I’ll contribute to a culture of ownership, transparency, and continuous improvement."
Help us improve this answer. / -
Where do you want to grow professionally over the next 2–3 years, and how do you invest in your development?
Employers ask this to see your growth mindset and alignment with company trajectory. In your answer, name specific skills and how you actively build them.
Answer Example: "I aim to deepen expertise in EU MDR/IVDR and SaMD cybersecurity while expanding leadership in regulatory strategy and people development. I invest through RAPS/AAMI courses, standards working groups, and mentoring. I also share learnings internally to raise the team’s capabilities."
Help us improve this answer. /